银屑病伴关节痛队列中发生银屑病关节炎的风险:探索亚临床银屑病关节炎阶段
在两个欧洲队列中纵向评估以关节痛定义的亚临床银屑病关节炎患者,384例银屑病患者平均随访33.0个月,亚临床银屑病关节炎311例(80.9%),其银屑病关节炎发病率为7.7/100患者年,发生银屑病关节炎风险显著高于单纯银屑病(HR=11.7,95%CI 1.57至86.7,p=0.016),12个月和36个月累积发病概率分别为9.4%和22.7%,关节肿胀是主要表现(82.1%)。
要点
- 银屑病伴关节痛(亚临床银屑病关节炎)者银屑病关节炎发病率7.7/100患者年,发生风险显著高于单纯银屑病(HR=11.7,95%CI 1.57至86.7,p=0.016)。
- 亚临床银屑病关节炎的银屑病关节炎累积发病概率12个月为9.4%(95%CI 4.7%至10.6%),36个月为22.7%(95%CI 17.2%至28.6%)。
- 新发银屑病关节炎以周围关节肿胀为主要表现(82.1%),诊断前数月58.9%报告炎症症状、83.9%有非炎症症状。
核心结论
- 亚临床银屑病关节炎患者发生银屑病关节炎的概率相对较高,强调出现肌肉骨骼症状时对银屑病关节炎预防的重要性。
- 新发银屑病关节炎以关节肿胀为主要特征,可能反映临床识别关节肿胀的信心。
研究设计与样本
- 在两个欧洲队列中对银屑病患者(主要为亚临床银屑病关节炎)进行纵向评估,主要结局为新发银屑病关节炎。
- 共纳入384例银屑病患者,平均随访33.0(±20.9)个月。
- 收集银屑病关节炎诊断前的肌肉骨骼症状,包括炎症性和非炎症性症状。
- 采用生存分析和累积发病率函数(CIF)分析银屑病关节炎的发生。
主要发现
- 384例中311例(80.9%)为亚临床银屑病关节炎,银屑病关节炎发病率为7.7/100患者年。
- 亚临床银屑病关节炎较单纯银屑病发生银屑病关节炎的风险更高(HR=11.7,95%CI 1.57至86.7,p=0.016)。
- CIF估计的新发银屑病关节炎概率12个月为9.4%(95%CI 4.7%至10.6%),36个月为22.7%(95%CI 17.2%至28.6%)。
- 58.9%的病例在银屑病关节炎诊断前数月报告炎症症状,83.9%在诊断前有非炎症症状。
- 周围关节肿胀是新发银屑病关节炎的主要表现模式(82.1%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) estimate the probability of PsA development in subclinical PsA, (2) characterise subclinical PsA symptoms and (3) determine the clinical patterns at PsA diagnosis. METHODS: Patients with PsO, mainly subclinical PsA, were evaluated longitudinally in two European cohorts. The key outcome was new-onset PsA. Musculoskeletal symptoms including inflammatory and non-inflammatory symptoms before PsA diagnosis were collected. Occurrence of PsA was analysed with survival analysis and cumulative incidence functions (CIFs). RESULTS: 384 patients with PsO were included with a mean follow-up of 33.0 (±20.9) months. 311 of 384 (80.9%) had subclinical PsA with a PsA incidence rate of 7.7 per 100 patient-years. Subclinical PsA displayed a higher risk of PsA development compared with PsO (HR=11.7 (95% CI 1.57 to 86.7), p=0.016). The probability of new-onset PsA estimated by the CIF was 9.4% (95% CI 4.7% to 10.6%) at month 12 and 22.7% (95% CI 17.2% to 28.6%) at month 36. 58.9% of cases reported inflammatory symptoms in the months immediately prior to PsA diagnosis but prior non-inflammatory symptoms were evident in 83.9% prior to PsA diagnosis. Peripheral joint swelling was the predominant PsA presentation pattern (82.1%). CONCLUSIONS: The probability of PsA development among subclinical PsA was relatively high, emphasising the importance of emergent musculoskeletal symptoms when aiming for PsA prevention. Joint swelling was the dominant feature in new-onset PsA, likely reflecting clinical confidence in recognising joint swelling.
引用
- Zabotti A, Fagni F, Gossec L, et al. Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open. 2024. PMID: 38599649. doi:10.1136/rmdopen-2024-004314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。